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A B S T R A C T
Mitochondria damage plays a critical role in acetaminophen (APAP)-induced necrosis and liver injury. Cells can
adapt and protect themselves by removing damaged mitochondria via mitophagy. PINK1-Parkin pathway is one
of the major pathways that regulate mitophagy but its role in APAP-induced liver injury is still elusive. We
investigated the role of PINK1-Parkin pathway in hepatocyte mitophagy in APAP-induced liver injury in mice.
Wild-type (WT), PINK1 knockout (KO), Parkin KO, and PINK1 and Parkin double KO (DKO) mice were treated
with APAP for different time points. Liver injury was determined by measuring serum alanine aminotransferase
(ALT) activity, H&E staining as well as TUNEL staining of liver tissues. Tandem fluorescent-tagged inner mi-
tochondrial membrane protein Cox8 (Cox8-GFP-mCherry) can be used to monitor mitophagy based on different
pH stability of GFP and mCherry fluorescent proteins. We overexpressed Cox8-GFP-mCherry in mouse livers via
tail vein injection of an adenovirus Cox8-GFP-mCherry. Mitophagy was assessed by confocal microscopy for
Cox8-GFP-mCherry puncta, electron microscopy (EM) analysis for mitophagosomes and western blot analysis for
mitochondrial proteins. Parkin KO and PINK1 KO mice improved the survival after treatment with APAP al-
though the serum levels of ALT were not significantly different among PINK1 KO, Parkin KO and WT mice. We
only found mild defects of mitophagy in PINK1 KO or Parkin KO mice after APAP, and improved survival in
PINK1 KO and Parkin KO mice could be due to other functions of PINK1 and Parkin independent of mitophagy.
In contrast, APAP-induced mitophagy was significantly impaired in PINK1-Parkin DKO mice. PINK1-Parkin DKO
mice had further elevated serum levels of ALT and increased mortality after APAP administration. In conclusion,
our results demonstrated that PINK1-Parkin signaling pathway plays a critical role in APAP-induced mitophagy
and liver injury.
1. Introduction
Acetaminophen (APAP) overdose-induced liver injury remains the
most frequent cause of acute liver failure in the US and other western
countries. Decades of work from many laboratories have led to the
enriched understanding of APAP overdose-induced liver injury [1–6].
Following APAP overdose, hepatic levels of N-acetyl-p-benzoquinone
imine (NAPQI) increased via the metabolism mediated by cytochrome
P450 2E1 (Cyp2e1) and Cyp1a2. Excessive production of NAPQI then
depletes intracellular and mitochondrial glutathione (GSH) within the
liver whereas the remaining NAPQI forms covalent links with cellular
proteins to form APAP protein adducts (APAP-AD). Some of the pro-
teins are mitochondrial proteins resulting in mitochondrial damage and
necrotic cell death in the liver [6].
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We previously demonstrated that autophagy protects against APAP-
induced liver injury via removal of APAP-AD and damaged mitochon-
dria [7–9]. Autophagic removal of damaged mitochondria is mediated
by a selective autophagy process termed as mitophagy. Among the
mitophagy signaling pathways, phosphatase and tensin homolog
(PTEN)-induced kinase 1 (PINK1)-Parkin pathway is so far the best
characterized [10,11]. In healthy mitochondria, PINK1 is cleaved by
the inner mitochondrial membrane protease PARL and the truncated
form of PINK1 is released into the cytosol for N-end recognition and
degraded by the proteasome [12]. In damaged and depolarized mi-
tochondria, PINK1 is stabilized on the outer mitochondrial membrane
[13–15]. Parkin is an E3 ligase that generally sits in the cytoplasm
under normal conditions. Stabilized PINK1 on dysfunctional mi-
tochondria phosphorylates Ser65 on ubiquitin and Ser65 within Par-
kin's UBL domain that not only leads to the recruitment of Parkin to
mitochondria but also enhances Parkin E3 ligase activity resulting in
outer mitochondrial membrane protein ubiquitination [16]. In contrast,
PTEN-L, a newly identified isoform of PTEN, negatively regulates mi-
tophagy by dephosphorylating ubiquitin via its protein phosphatase
activity [17]. Ubiquitinated mitochondria then further recruit autop-
hagy receptor proteins such as NDP52, optineurin (OPTN) and
SQSTM1/p62 (hereafter referred to as p62) to mitochondria to trigger
the selective mitophagy [10,11,18,19]. Most published data from ear-
lier genetic Drosophila and cultured mammalian cell models suggest a
linear PINK1-Parkin mitophagy pathway, which places PINK1 upstream
of Parkin [15,20]. However, recent evidence suggests a new model that
PINK1 alone can also induce mitophagy independent of Parkin via di-
rectly recruit NDP52 and OPTN, two other mitophagy receptor pro-
teins, to mitochondria [21].
Although we now understand extensively the molecular details by
which PINK1-Parkin regulates mitophagy, most of the known me-
chanisms are derived from cell culture studies that overexpress exo-
genous Parkin. Due to the lack of reliable quantitative mitophagy as-
says, relatively few studies were conducted to determine the role of
PINK1-Parkin in mitophagy under pathophysiologically relevant in vivo
conditions. We recently demonstrated that APAP increases Parkin
translocation to mitochondria, which is associated with increased ubi-
quitination of mitochondrial proteins and mitophagy in mouse livers
[8]. These data imply that Parkin-mediated mitophagy may be pro-
tective against APAP-induced liver injury by removing damaged mi-
tochondria. Unexpectedly, we also found that mitophagy still occurs in
APAP-treated Parkin knockout (KO) mouse livers and that Parkin KO
mice are resistant to APAP-induced liver injury [11], suggesting other
compensatory mechanisms may be activated to induce mitophagy in
Parkin KO mouse livers. The aim of the present study was to determine
the role of PINK1 and Parkin in APAP-induced mitophagy and liver
injury, and whether PINK1-mediated mitophagy would serve as a
compensatory mechanism in the absence of Parkin in APAP-treated
mouse livers. To achieve a more reliable quantitative measure of mi-
tophagy in mouse livers, we generated an adenovirus vector that carries
a mitochondrial inner membrane-targeted tandem GFP-mCherry fusion
protein. To determine the possible reciprocal compensatory role of
PINK1 and Parkin in APAP-induced mitophagy and liver injury, we also
generated PINK1 and Parkin double KO (DKO) mice. We found that
APAP-induced mitophagy was significantly blunted in the PINK1 and
Parkin DKO mice. As a result, PINK1 and Parkin DKO mice had more
severe liver damage and increased mortality compared with either wild-
type (WT) mice or single PINK1 KO or Parkin KO mice after APAP.
2. Materials and methods
2.1. Antibodies and reagents
The following antibodies were used for western blot analysis: Parkin
(Santa-Cruz, SC-32282), Ubiquitin (Santa Cruz, SC-8017), p62 (Abnova,
H00008878-M01), β-Actin (Sigma, A5441), Cyp2e1 (Abcam, ab19140),
phosphorylated JNK (4668S), JNK (BD, 554285), Oxphos rodent anti-
body cocktail (Abcam, ab110413), and voltage-dependent anion
channel (VDAC) (Calbiochem, 529534). The APAP-adduct antibody
was a gift from Dr. Lance Pohl (NIH) [22]. Horseradish peroxidase-
conjugated antibodies were from Jackson ImmunoResearch Lab. Ade-
novirus (Ad) Cox8-GFP-mCherry was produced in collaboration with
Vector Biolabs (Malvern, PA). In situ cell death detection kit (Cat#
11684809910) was purchased from Roche. The kit for alanine amino-
transferase (ALT) assay was purchased from Pointe Scientific (A7526-
450). APAP and other chemicals were either purchased from Sigma-
Aldrich or Thermo Fisher Scientific.
2.2. Animal experiments
WT C57BL/6J, PINK1 KO (stock# 017946) and Parkin KO (Stock#
006582) were purchased from the Jackson Laboratory. PINK1 and
Parkin DKO mice were generated by crossing PINK1 KO mice with
Parkin KO mice. Atg5 Flox/Flox (Atg5 F/F) mice (C57BL/6/129) were
generated by Dr. N. Mizushima and were backcrossed with C57BL/6J
for another 10 generations before further crossing them with Albumin-
Cre mice (Alb-Cre, C57BL/6) (Jackson Laboratory) as described pre-
viously [23].
Male 8 to 12 week-old mice were treated with APAP (500mg/kg) or
saline by intraperitoneal injection. Afterwards, mice were euthanized at
2, 6, or 24 h. For the overexpression of Cox8-GFP-mCherry experiments,
mice were first given adenovirus (Ad)-Cox8-GFP-mCherry
(5×108 PFU/mouse, i.v) for 5 days followed by APAP (500mg/kg) for
6 h. All animals received humane care, and all protocols were approved
by the Institutional Animal Care and Use Committee at the University of
Kansas Medical Center.
Mouse livers and blood were collected. Hepatic function was eval-
uated by measuring serum alanine aminotransferase (ALT) activities.
Formalin-fixed liver tissues were embedded in paraffin and cut into 5-
μm sections before staining with hematoxylin and eosin (H&E) or
terminal dUTP nick-end labeling (TUNEL).
2.3. Confocal and electron microscopy for mitophagy in vitro and in vivo
Cryo-liver sections from saline and APAP-treated mice that over-
expressed Cox8-GFP-mCherry were further stained with Hoechst33342
(1 μg/ml) followed by confocal microscopy using a Leica confocal mi-
croscope. Images were acquired digitally using an oil lens at 40×. More
than 5 images were taken from one mouse liver section and the number
of red-only puncta in each cell was counted in more than 18 cells per
mouse from 3 different mice. For the electron microscopy (EM), liver
tissues were fixed with 2% glutaraldehyde in 0.1M phosphate buffer
(pH 7.4) followed by 1% OsO4. After dehydration, thin sections were
stained with uranyl acetate and lead citrate for observation under a
JEM 1016CX electron microscope. The number of autophagosomes that
enveloped with mitochondria (mitophagosomes) was counted and
normalized to the cytosolic areas using a SPOT software (SPOT
Imaging). More than 10 different cells were analyzed in each group.
Murine hepatocytes were isolated according to the methods described
previously [24]. Cells were cultured in Williams Medium E and main-
tained in a 37 °C incubator with 5% CO2. To examine mitophagy in
primary hepatocytes, primary hepatocytes were seeded in a 12 well-
plate (2×105 in each well) and infected with adenovirus-Cox8-GFP-
mCherry (5 moi) for 24 h. Cells were fixed with 4% paraformaldehyde
in phosphate buffered saline (PBS) and kept at 4 °C for microscopy.
Fluorescence images were acquired under a Nikon Eclipse 200 fluor-
escence microscope with MetaMorph software.
2.4. Western blot analysis
Total liver lysates were prepared using RIPA buffer (1% NP40, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl (lauryl) sulfate). Heavy
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membrane (HM) fractions mainly enriched with mitochondria and cy-
tosolic fractions were prepared as described previously [25]. Briefly,
liver tissues were homogenized in HIM buffer (200mM mannitol,
70 mM sucrose, 5 mM Hepes, 0.5mM EGTA (pH 7.5) containing 1%
protease inhibitors) using a dounce homogenizer. Homogenates were
centrifuged at 1000×g to remove debris, and the supernatant was
centrifuged at 10,000×g for 10min to separate HM and cytosolic
fractions. The supernatant was kept as the cytosolic fraction, and the
pellet containing the HM fraction was further washed by centrifugation
and re-suspended in HIM buffer. To determine the levels of mitochon-
drial oxidative phosphorylation (OXPHOS) proteins, 30 μg protein were
mixed with the loading sample buffer at room temperature without heat
boiling. Protein (30 μg) was separated by a 12%–15% SDS-PAGE gel
before transfer to a PVDF membrane. Membranes were probed using
indicated primary and secondary antibodies and developed with Su-
perSignal West Pico chemiluminescent substrate (Pierce, 34080) and
high sensitivity for chemiluminescent substrate (Millipore,
WBKLS0500).
2.5. Glutathione (GSH) assay and APAP-protein adducts measurement
GSH levels in mouse livers were detected using a modified Tietze
assay [26]. Briefly, liver tissues were homogenized in sulfosalicylic acid
(3%) followed by centrifugation and dilution in potassium phosphate
buffer. Samples were then subjected to a cycling reaction using glu-
tathione reductase and dithionitrobenzoic acid, and GSH levels were
determined by spectrophotometry [27]. The levels of serum and liver
APAP-adducts were determined by western blot analysis using an anti-
APAP-adduct antibody as we described previously [7].
2.6. Measurement of mitochondria bioenergetics
This was performed as we recently reported [28]. Briefly, livers
were homogenized in mitochondria isolation buffer (70mM sucrose,
210mM mannitol, 5 mM HEPES, 1mM EGTA and 0.5% (w/v) fatty
acid-free BSA; pH 7.2). Homogenates were centrifuged twice at
1000×g for 10min at 4 °C and the supernatants were centrifuged once
at 8000×g for 10min at 4 °C. The mitochondrial pellets were sus-
pended in the isolation buffer and total proteins were determined using
BCA protein assay. All mitochondrial respiration assays were performed
using an XF24x3 Extracellular Flux Analyzer by Seahorse Bioscience
(North Billerica, Massachusetts). Mitochondria from 2 to 3 mice/group
were pooled and the assays were done in triplicate. Isolated liver mi-
tochondria were suspended in cold mitochondrial assay solution (1×
MAS: 70mM sucrose, 220mM mannitol, 10mM KH2PO4, 5mM MgCl2,
2 mM HEPES, 1 mM EGTA and 0.2% (w/v) fatty acid-free BSA, pH
7.2 at 37 °C) containing substrate (10 mM succinate + 2 μM rotenone)
to a final concentration of 0.2 mg/ml protein, and 50 μl of this mi-
tochondrial suspension was plated to each well (except for background
correction wells). The plate was centrifuged at 2000×g for 20min at
4 °C and 450 μl of 1× MAS-substrate solution was added to each well.
The sensor cartridge was loaded with port A, 40mM ADP (4mM final);
port B, 25 μg/ml oligomycin (2.5 μg/ml final); port C, 40 μM FCCP
(4 μM final); and port D, 40 μM antimycin A (4 μM final) to measure the
bio-energetic profile. The plate was pre-warmed to 37 °C and trans-
ferred to the XF24 instrument. The respiration was measured in a
coupled state with substrate present (basal respiration), followed by
State 3 (phosphorylating respiration, in the presence of ADP and sub-
strate), State 4o (leak state induced with the addition of oligomycin -
inhibitor of ATP synthase), and then maximal uncoupler (FCCP)-
Fig. 1. PINK1 and Parkin DKO mice are more susceptible to APAP-induced liver injury. Male WT, Parkin KO, PINK1 KO, PINK1 and Parkin DKO (C57BL/6J) mice
were treated with APAP (500mg/kg, i.p.) or saline for 6 and 24 h. (A) Serum ALT level. Data are shown as mean ± SE (n = 5–13). *p < 0.05, One-way ANOVA
analysis. (B) Mouse survival rate after APAP treatment (n=7–15). (C) Representative images from H&E staining and (D) TUNEL staining in mouse livers. Dot line-
circled areas represent necrotic areas.
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stimulated respiration (State 3u). At the end, antimycin A (complex III
inhibitor) is added to inhibit mitochondrial respiration completely.
2.7. Statistical analysis
All analyses were performed using Student's t-test or one-way
ANOVA analysis where appropriate. Difference was considered sig-
nificant at P value less than 0.05.
3. Results
3.1. Double deletion of PINK1 and Parkin exacerbates APAP-induced liver
injury and mortality in mice
Similar to Parkin KO mice that we reported previously [8], we found
that PINK1 KO mice had decreased serum ALT levels at 6 h compared
with WT mice after APAP. After 24 h treatment with APAP, levels of
ALT in Parkin KO mice remained as low as in 6 h, but the serum ALT
levels increased slightly in both WT and PINK1 KO mice. In contrast,
DKO mice had significantly higher serum levels of ALT than WT mice or
either PINK1 or Parkin single KO mice at 6 h after APAP treatment
(Fig. 1A). We found that the mortality of DKO mice doubled compared
with WT mice (41.7% vs 23.1%) whereas all the PINK1 KO and Parkin
KO mice survived after APAP treatment for 24 h (Fig. 1B). Because we
could only assess the ALT values in the survived DKO mice, which may
explain why the ALT levels were comparable among the WT, PINK1 KO
and DKO mice at 24 h. Consistent with the serum ALT and mouse sur-
vival data, liver H&E and TUNEL staining revealed increased necrotic
areas in the DKO mice compared with PINK1 KO and WT mice after
APAP treatment for 6 and 24 h (Fig. 1C&D). Taken together, these
findings indicate that PINK1 and Parkin DKO mice are more susceptible
to APAP-induced liver injury and mortality in mice. Increased liver
injury in PINK1 KO but not in Parkin KO mice after APAP treatment for
24 h also suggests that PINK1 may have additional functions in addition
to serving as a linear upstream regulator of Parkin-mediated mito-
phagy.
3.2. Delayed glutathione (GSH) recovery in PINK1 and Parkin DKO mice
after APAP
We found that the hepatic levels of Cyp2e1 were comparable among
all these different genotypes of mice (Fig. 2A). Consistent with the
Cyp2e1 data, we found that hepatic GSH levels decreased markedly to
almost the same levels among WT, PINK1 KO, Parkin KO and DKO mice
after 2 h of APAP treatment. Western blot analysis revealed completely
deletion of Parkin protein in Parkin KO and DKO mice. Using the cur-
rent commercial PINK1 antibody, we could not detect PINK1 at the
basal or after APAP treatment in mouse livers. However, we have
confirmed the deletion of PINK1 by PCR genotyping and qRT-PCR for
hepatic PINK1 mRNA expression (data not shown). These data suggest
that PINK1 KO, Parkin KO and DKO mice may not affect the bioacti-
vation and metabolism of APAP. However, while WT, PINK1 KO and
Parkin KO mice had the same recovery rate of hepatic GSH, the levels of
hepatic GSH remained low in DKO mice after APAP treatment for 6 h
(Fig. 2B). Together these results indicate that PINK1 KO as well as
PINK1 and Parkin DKO mice do not affect APAP metabolism and DKO
mice have delayed hepatic GSH recovery.
3.3. Decreased hepatic levels of mitochondrial ubiquitination and p62
translocation in PINK1 and Parkin DKO mice after APAP treatment
Parkin recruitment to mitochondria and subsequent mitochondrial
ubiquitination is a crucial process to trigger mitophagy [29]. We found
that APAP increased the levels of mitochondrial Parkin after APAP
treatment in WT mice, which is in agreement with our previous report
[8]. However, APAP did not increase mitochondrial Parkin transloca-
tion in PINK1 KO mice, suggesting that PINK1 is required for Parkin
mitochondrial translocation in mouse livers (Fig. 3A), which is con-
sistent with the findings in various cell culture studies [14,15]. Com-
pared with the saline treatment group, APAP treatment markedly in-
creased mitochondrial ubiquitination in WT, Pink1 KO and Parkin KO
mice, which were blunted in PINK1 and Parkin DKO mice. The basal
level of mitochondrial ubiquitination was relatively higher in PINK1 KO
mice (saline-treated group), which only slightly increased after APAP
treatment. The levels of mitochondrial p62 increased in WT, PINK1 KO
and Parkin KO mice but not in DKO mice after APAP treatment
(Fig. 3B). Importantly, when we placed isolated mitochondria from all
four different genotype mice after APAP treatment on the same blot for
the direct comparison, we found that mitochondrial ubiquitination
occurred in WT, PINK1 KO and Parkin KO mice whereas only minimal
levels of mitochondrial ubiquitination were detected in DKO mice
(Fig. 3C). Similarly, APAP-induced levels of p62 mitochondrial trans-
location slightly decreased in PINK1 KO and Parkin KO mice but
markedly decreased in PINK1 and Parkin DKO mice compared with WT
mice. These data suggest that single genetic deletion of either PINK1 or
Parkin is not sufficient to significantly blunt APAP-induced mitochon-
drial ubiquitination and p62 translocation. The markedly decreased
mitochondrial ubiquitination and p62 translocation in APAP-treated
DKO mice may imply that PINK1 could compensate for the loss of
Parkin and vice versa that Parkin could compensate for the loss of
PINK1 at least partially in regulating APAP-induced mitochondria
ubiquitination and p62 translocation and subsequent mitophagy.
3.4. Impaired hepatic mitophagy and increased mitochondrial dysfunction
in APAP-treated PINK1 and Parkin DKO mice
To better determine mitophagy after APAP treatment in hepato-
cytes, we developed a novel tandem Cox8-GFP-mCherry fusion protein
Fig. 2. Delayed glutathione (GSH) recovery in PINK1 and Parkin DKO mice after APAP treatment. Male WT, Parkin KO, PINK1 KO, PINK1 and Parkin DKO (C57BL/
6J) mice were treated with APAP (500mg/kg, i.p.) or saline for 2 and 6 h. (A) Total liver lysates from mice that were treated with APAP (6 h) and saline were
subjected to western blot analysis. (B) Hepatic GSH levels were measured. Data are presented as mean ± SE (n=3). ∗p < 0.05 as compared with WT mice. One-
way ANOVA analysis.
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that targets the mitochondrial inner membrane in hepatocytes using an
adenovirus-Cox8-GFP-mCherry. In this assay, mCherry fluorescence is
more stable in acidic compartments whereas GFP fluorescence is ra-
pidly quenched, which is similar to the tandem mCherry-GFP-LC3 that
is widely used to monitor autophagic flux [30]. Accordingly, once mi-
tochondria are delivered to autolysosomes via the fusion of lysosomes
with autophagosomes that have enveloped mitochondria, the numbers
of red only (mCherry) puncta increased. Failure to deliver mitochondria
to acidic autolysosomes or suppression of lysosomal degradation (i.e.,
increase lysosomal pH) would decrease the number of red mitochon-
dria. We first validated the use of Cox8-GFP-mCherry to monitor mi-
tophagy in primary cultured hepatocytes that were isolated from WT
and liver-specific Atg5 KO mice. We found that Cox8-GFP-mCherry
showed spherical or tubular like typical mitochondrial structure in
primary mouse hepatocytes from WT and Atg5 KO mice (Fig. 4A),
suggesting successful overexpression and targeting of Cox8-GFP-
mCherry to mitochondria in hepatocytes. We found many red only
(mCherry only) puncta in WT hepatocytes, which reflects the basal level
mitophagy in primary cultured hepatocytes. In contrast, Cox8-GFP-
mCherry displayed almost exclusively yellow color mitochondria in
Atg5 KO hepatocytes, suggesting a marked decrease of mitophagy
(Fig. 4). These data indicate that Cox8-GFP-mCherry can be used to
specifically monitor mitophagy in hepatocytes. To further determine
mitophagy in mouse livers using Cox8-GFP-mCherry after APAP, we
overexpressed Cox8-GFP-mCherry in mouse livers by tail vein injection
of Ad-Cox8-GFP-mCherry. Similar to the primary cultured hepatocytes,
we also found Cox8-GFP-mCherry displayed spherical or tubular like
typical mitochondrial structure in hepatocytes of mouse livers. In
saline-treated WT, PINK1 KO and Parkin KO mouse livers, we found
approximately average 18 red-only puncta per hepatocyte, which may
reflect the basal mitophagy in the livers of these mice. In contrast, there
were approximately 12 red-only puncta per hepatocytes in saline-
Fig. 3. Decreased hepatic levels of mitochondrial ubiquitination and p62 translocation in PINK1 and Parkin DKO mice after APAP treatment. Male WT, Parkin KO,
PINK1 KO, PINK1 and Parkin DKO (C57BL/6J) mice were treated with APAP (500mg/kg, i.p.) or saline for 6 h. (A) Liver cytosolic and mitochondrial fractions were
isolated and subjected to western blot analysis for Parkin and (B) for ubiquitin and p62. β-Actin and VDAC were used as loading controls for cytosol and mi-
tochondria, respectively. Densitometry analysis were performed for ubiquitin (ub) and p62 and values were normalized either to β-Actin or VDAC. Data are
means ± SE (n= 3 mice). (C) Mitochondrial fractions from APAP-treated WT, Parkin KO, PINK1 KO and DKO mice were subjected to western blot analysis.
Densitometry analysis were performed for ubiquitin (ub) and p62 and values were normalized to VDAC. Data are means ± SE (n= 3 mice). A photograph of
Ponceau S red staining membrane serves as a loading control.
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treated PINK1 and Parkin DKO mouse livers. APAP treatment increased
the number of red-only puncta significantly compared with saline-
treated mice, which was significantly blunted in PINK1 and Parkin DKO
mice (Fig. 5A&B).
To further determine APAP-induced mitophagy in WT and PINK1
and Parkin DKO mice, we compared and quantified the number of
autophagosomes and lysosomes containing mitochondria (hereafter
referred to as mitophagosomes) by EM analysis. We found that APAP-
treatment increased the number of hepatic mitophagosomes in WT,
PINK1 KO, and PINK1 and Parkin DKO mice compared with their re-
spective saline-treated control mice. However, the number of mito-
phagosomes is much lower in APAP-treated DKO mice than in WT and
Fig. 4. Cox8-GFP-mCherry assay reveals that Atg5 KO hepatocyte have decreased mitophagy. Primary hepatocytes were isolated from WT and liver-specific Atg5 KO
mice and infected with Ad-Cox8-GFP-mCherry (5 moi) for 24 h. Cells were fixed and followed by fluorescence microscopy. Representative images are shown. Right
panels are enlarged photographs from the boxed areas. Arrow denotes the red-only puncta. Bar: 10 μm.
Fig. 5. Decreased red puncta numbers of Cox8-GFP-mCherry in APAP-treated PINK1 and Parkin DKO mouse livers. Male WT, PINK1 KO, Parkin KO, and PINK1 and
Parkin DKO (C57BL/6J) mice were injected with Ad-Cox8-GFP-mCherry (5×108 PFU/mouse, i.v) for 5 days followed by APAP (500mg/kg) for 6 h. Cryo-liver
sections were subjected to confocal microscopy. (A) Representative confocal microscopy images of Cox8-GFP-mCherry of mouse livers. The right panel is from the
boxed area of the next panel. Arrows denote red puncta. Scale Bar: 10 μm. (B) Average number of red-only puncta per hepatocyte. Data are means ± SE (n = 3
mice). Eighteen to thirty-two hepatocytes were counted in each mouse. *p < 0.05; One-way ANOVA analysis.
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PINK1 KO mice (Fig. 6A&B). While these changes did not reach sta-
tistical significance due to the variations, these data confirmed that the
structures of autophagosomes that enveloped with mitochondria (mi-
tophagosomes) could be detected in APAP-treated mouse livers re-
gardless of the presence of PINK1 or Parkin. However, the very low
levels of mitophagosomes from the EM studies together with the low
levels of red-only puncta in PINK1 and Parkin DKO mice from the Cox8-
GFP-mCherry assay, suggesting that APAP-induced mitophagy is largely
dependent on PINK1-Parkin pathway in the mouse livers.
3.5. Elevated levels of hepatic mitochondrial proteins and decreased
mitochondrial respiration in APAP-treated PINK1 and Parkin DKO mice
We next determined the levels of several mitochondrial oxidative
phosphorylation (OXPHOS) proteins (consist of complex I, II, III, IV and
V) after APAP treatment. As can be seen, APAP treatment led to an
overall decrease of OXPHOS complex proteins at 6 and 24 h in WT
mice. In Parkin KO mice, the levels of the OXPHOS complex proteins
remained unchanged after APAP treatment for 6 h but the levels of
complex I significantly decreased after APAP treatment for 24 h com-
pared to the saline-treated group. In contrast, after APAP treatment, the
levels of the OXPHOS complex proteins remained almost unchanged at
both 6 and 24 h in PINK1 KO and DKO mice except that the level of
complex I deceased 50% in PINK1 KO compared with the saline control
group (Fig. 7A&B).
To make a direct comparison of mitochondrial proteins after APAP,
we placed proteins from all saline-treated and APAP-treated different
genotype of mice on the same blot. The basal levels of OXPHOS were
not significantly different among the different genotype mice except
that the levels of complex I were higher in PINK1 KO, Parkin KO and
DKO mice compared with the WT mice. After APAP treatment, levels of
OXPHOS protein were also comparable among the different genotype
mice but the levels of complex IV were significantly higher in DKO mice
compared with the other mice (Fig. 7C&D). Moreover, when isolated
mitochondria from APAP-treated different genotype of mice were used
to measure the mitochondrial oxygen consumption rate (OCR) using
Seahorse XF24x3 extracellular flux analyzer, we found no difference in
either basal respiration, ATP-synthesizing respiration (state III) or
maximum respiratory capacity induced by uncoupling with FCCP (state
3u) among WT, PINK1 KO and Parkin KO mice. In contrast, all the
different states of mitochondrial respiration decreased significantly in
DKO mice compared with WT, PINK1 KO and Parkin KO mice either
treated with saline or APAP (Fig. 7E). It should be noted that the OCR
change patterns remained the same when the values of antimycin were
subtracted (data not shown). It has been generally thought that the
outer mitochondrial membrane proteins are largely degraded via the
Fig. 6. Impaired hepatic mitophagy in APAP-treated
PINK1/Parkin DKO mice. Male WT, PINK1 KO,
PINK1 and Parkin DKO (C57BL/6J) mice were
treated with APAP (500mg/kg, i.p.) or saline for 6 h.
(A) Representative EM images from WT, PINK1 KO,
Parkin KO, and PINK1/Parkin DKO mouse livers are
shown. Right panels are enlarged photographs from
the boxed areas in the left panels. Arrows denote for
the mitophagosomes. M=mitochondria,
N= nucleus. Bar= 500 nm. (B) Quantification of
the number of mitophagosomes from EM. Data
shown are dot plot of the mitophagosomes that
contain mitochondria from at least 10 images of the
mouse liver.
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ubiquitin proteasome system whereas the inner mitochondrial mem-
brane proteins are degraded via autophagy [29,31]. We found that the
levels of Mfn1, Tom20 and VDAC, three outer mitochondrial membrane
proteins, markedly decreased in WT mice after APAP treatment. In
contrast, no degradation of Tom20 and VDAC was observed in PINK1
KO, Parkin KO and DKO mice after APAP treatment. The levels of Mfn1
only decreased in PINK1 KO and Parkin KO mice after prolonged
treatment with APAP for 24 h but levels of Mfn1 remained unchanged
in DKO mice after APAP treatment (Fig. 8 A&B). Together, these data
suggest that PINK1 and Parkin DKO mice have generally less
mitochondrial OXPHOS complex protein degradation (likely due to
impaired mitophagy) and outer mitochondrial membrane protein de-
gradation (likely due to decreased ubiquitination and proteasomal de-
gradation) after APAP treatment compared with WT, PINK1 KO and
Parkin KO mice. Impaired mitophagy in APAP-treated PINK1 and
Parkin DKO mice may also lead to dysfunctional mitochondrial re-
spiration in mouse livers despite an overall increase in the OXPHOS
complexes.
Fig. 7. Inner mitochondrial membrane proteins are not degraded but mitochondrial respiration decreased in APAP-treated PINK1 and Parkin DKO mice. Male WT,
PINK1 KO, Parkin KO, PINK1 and Parkin DKO (C57BL/6J) mice were treated with APAP (500mg/kg, i.p.) or saline for 6 and 24 h. (A) Total liver lysates were
subjected to western blot analysis. (B) Densitometry analysis of (A). Data are means ± SE (n=3). (C) Total liver lysates from saline-treated and APAP-treated WT,
PINK1 KO, Parkin KO, PINK1 and Parkin DKO mice were subjected to western blot analysis. (D) Densitometry analysis of (C). Data are means ± SE (n = 3).
*p < 0.05 One-way ANOVA analysis. (E) Isolated hepatic mitochondria were subjected to the analysis of mitochondrial bioenergetics using Seahorse XF24x3
analyzer. All results are expressed as means ± SE (n = 3) and experiments were repeated more than 3 times. *p < 0.05 Student t-test.
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3.6. Increased JNK activation in the early phase but not late phase of APAP-
induced liver injury in PINK1 and Parkin DKO mice
We found the levels of phosphorylated JNK (pJNK) increased at 6 h
but decreased at 24 h after APAP treatment in WT and DKO mice. In
contrast, the levels of pJNK increased at 6 h and sustained at 24 h after
APAP treatment in PINK1 KO mice (Fig. 9A). When liver lysates from
APAP-treated mice with different genotype were placed on the same
blot, it showed higher levels of pJNK in PINK1 KO and DKO mice
compared to WT or Parkin KO mice after APAP treatment for 6 h. In-
terestingly, the levels of pJNK remained remarkably higher in PINK1
KO mice but were almost undetectable in WT, Parkin KO, PINK1 and
Parkin DKO mice after APAP treatment for 24 h (Fig. 9B). These data
indicate that the levels of JNK activation may be higher in PINK1 and
Parkin DKO mice at the early phase but not the late phase after APAP
treatment. In contrast, the levels of JNK activation are sustained at both
the early and late phase of APAP treatment in PINK1 KO mice (see
Fig. 9B).
4. Discussion
We previously reported that Parkin differentially regulates APAP-
induced mitophagy [8]. The role of Parkin in APAP-induced liver injury
depends on whether Parkin is chronically deleted or acutely knocked
down in mouse livers. We found that mitophagy still occurred in he-
patocytes of Parkin KO mice after APAP treatment, but acute knock-
down of Parkin markedly decreased APAP-induced mitophagy [8].
These observations have led us to speculate that Parkin KO mice may
have adapted and use alternative Parkin-independent compensatory
pathways to trigger mitophagy. Under acute knockdown conditions, the
adaptive response may not have been initiated. Parkin KO mice are
viable and only have mild and inconsistent mitochondrial phenotypes
[8,32,33]. All these earlier studies together with ours suggest that re-
dundant proteins may exist to compensate for the loss of Parkin.
However, such adaptive compensatory mechanisms are largely un-
known and have not been explored in APAP-induced mitophagy and
liver injury.
Several other ubiquitin E3 ligases have been reported that can also
trigger mitophagy in addition to Parkin. In a high-content, image-based,
genome-wide small interfering RNA screen, SMURF1, a C2-domain
containing protein that has E3 ubiquitin ligase activity, induces mito-
phagy in cultured cells. An increased number of damaged mitochondria
were found in the heart, brain and liver of SMURF1 KO mice [34].
During the elimination of paternal mitochondria in mouse embryos, it
was found that Parkin and MUL1, another E3 ubiquitin ligase, have
redundant roles in mitophagy [19]. Parkin KO cells have normal mi-
tophagy but further knockdown of MUL1 abolished mitophagy in
Parkin KO cells [19]. Compared with either WT, PINK1 or Parkin KO
mice, we found that the levels of mitochondrial ubiquitination mark-
edly decreased in PINK1 and Parkin DKO mice. Moreover, after APAP
treatment of PINK1 and Parkin DKO mice, the levels of mitochondrial
ubiquitination did not increase compared with saline-treated mice.
These data suggest that PINK1 and Parkin could be the dominate
pathway in regulating mitochondrial ubiquitination and mitophagy in
mouse livers after APAP. Other E3 ligases such as SMURF1 and MUL1
may only play a minor role in APAP-induced ubiquitination of mi-
tochondria and mitophagy. However, whether the residual mitochon-
drial ubiquitination in PINK1 and Parkin DKO mice is mediated by
SMURF1 and MUL1 remains to be studied in the future.
One of the key steps in mitophagy is the selective recognition of
damaged mitochondria by autophagosomes. The selective process for
mitochondria is mediated by mitophagy receptor proteins. Generally, a
mitophagy receptor must be present on mitochondria and can directly
interact with proteins of the autophagy machinery such as LC3 via the
LIR (LC3 interacting region) [11,35]. Several mitophagy receptor pro-
teins such as Nix, Bnip3 and Fundc1 may directly recruit the autophagy
machinery to mitochondria independent of PINK1 and Parkin. In con-
trast, p62 normally resides at cytosol but can translocate to ubiquiti-
nated mitochondria via direct binding with ubiquitin followed by the
recruitment of autophagosomes through direct interaction with LC3
[19,36,37]. Using EM and confocal microscopy of the mitophagy re-
porter protein Cox8-GFP-mCherry, we found that there were still some
basal levels of mitophagy in PINK1 and Parkin DKO mouse livers (albeit
mitophagy in DKO mouse livers did not further increase after APAP),
suggesting that some of the mitophagy receptor proteins could be re-
sponsible for the basal mitophagy in PINK1 and Parkin DKO
Fig. 8. APAP treatment decreased outer mitochondrial membrane protein Mfn1 and Tom20 in WT but not in PINK1 and Parkin DKO mice. Male WT, Parkin KO,
PINK1 KO, PINK1 and Parkin DKO (C57BL/6J) mice were treated with saline or APAP (500mg/kg, i.p.) for 6 and 24 h. (A) Total liver lysates were subjected to
western blot analysis. (B) Densitometry analysis of (A). Data are means ± SE (n=3).
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hepatocytes independent of PINK1 and Parkin. While it is beyond the
scope of this report, further studies are needed to further examine the
role of these receptor proteins in APAP-induced mitophagy and liver
injury. Recently, formation of mitochondrial-derived vesicles (MDVs), a
novel mitochondrial degradation pathway independent of mitophagy,
has been proposed [11,38,39]. MDVs are single membrane vesicles that
bud off damaged mitochondria, which contain some oxidized mi-
tochondrial proteins and fuse with endosomes and lysosomes for de-
gradation. Future studies are needed to determine whether some of the
basal mitochondrial turn over in PINK1 and Parkin DKO mice that we
observed are mediated by MDVs or not.
What are the advantages and disadvantages of using Ad-Cox8-GFP-
mCherry to monitor mitophagy in mouse livers? It should be noted that
a transgenic mouse line of Mito-QC, a tandem mCherry-GFP tag fused to
the mitochondrial targeting sequence of the outer mitochondrial
membrane protein, has been recently established to monitor mitophagy
in vivo [40]. However, as discussed above, most outer mitochondrial
membrane proteins are degraded by the ubiquitin proteasome system
during mitophagy whereas inner mitochondrial membrane proteins are
more specifically degraded by mitophagy [11]. Therefore, the use of
Cox8-GFP-mCherry may be more specific to monitor mitophagy in
mouse livers. Another advantage of using Ad-Cox8-GFP-mCherry is that
one can directly overexpress Cox8-GFP-mCherry in mouse livers of
different strains to avoid the time-consuming cross-breeding. However,
there are also some disadvantages and limitations of using Ad-Cox8-
GFP-mCherry to monitor mitophagy. The expression levels of Cox8-
GFP-mCherry vary in different cells due to the different amount of
adenovirus each cell received in particularly in liver tissues. Moreover,
adenovirus may cause some inflammatory response in the liver, which
may affect the sensitivity to different drugs including APAP.
One of the novel perspectives in our present study is that we de-
termined APAP-induced liver injury and mitophagy in PINK1 KO and
PINK1 and Parkin DKO mice. It has been thought that PINK1 acts up-
stream of Parkin as a linear pathway, in which PINK1 phosphorylates
both Parkin and ubiquitin to recruit Parkin to mitochondria for mi-
tochondrial outer membrane protein ubiquitination and mitophagy
[14,16,21]. We found that the phenotypes in PINK1 KO mice after
APAP treatment were largely similar to the Parkin KO mice. Both
Parkin KO and PINK1 KO showed decreased levels of serum of ALT at
6 h with better survival after APAP treatment, although PINK1 KO mice
showed higher levels of serum ALT at 24 h after APAP. APAP treatment
increased mitochondrial Parkin translocation in WT mice, which was
markedly blunted in PINK1 KO mice. These data suggest that PINK1
and Parkin likely also work in a linear pathway in mouse livers and
PINK1 acts upstream of Parkin, which is similar to those findings in
Drosophila melanogaster and mammalian cell culture studies [14,20].
However, compared with either WT, PINK1 KO or Parkin KO mice, the
levels of mitochondrial ubiquitination and mitophagy decreased dra-
matically in PINK1 and Parkin DKO mice after APAP treatment, sug-
gesting that it is possible that Parkin and PINK1 may also reciprocally
compensate for each other in addition to working in the linear pathway
in mouse livers. It should be noted that both PINK1 and Parkin have
other functions including regulating cell survival and proliferation in
addition to regulating mitophagy [41,42]. In addition, the whole body
PINK1 KO and Parkin KO mice may already have developed other
adaptive responses that influence the APAP-induced liver injury and
mortality independent of mitophagy. Future studies are needed to
identify these mitophagy-independent functions of loss of PINK1 or
Parkin, which contribute to the improved survival of APAP-treated
mice.
Fig. 9. Increased JNK activation in the early phase but not late phase of APAP-induced liver injury in PINK1 and Parkin DKO mice. Male WT, Parkin KO, PINK1 KO,
PINK1 and Parkin DKO (C57BL/6J) mice were treated with saline or APAP (500mg/kg, i.p.) for 6 and 24 h. (A) Total liver lysates were subjected to western blot
analysis. (B) Male WT, Parkin KO, PINK1 KO, PINK1 and Parkin DKO mice were treated with APAP (500mg/kg, i.p.) for 6 and 24 h. Total liver lysates were subjected
to western blot analysis. SE: Short exposure. LE: Longer exposure.
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How does PINK1-Parkin-mediated mitophagy protect against APAP-
induced liver injury? Mitochondria damage has been well recognized as
a central key mechanism contributing to APAP-induced necrosis by
releasing mitochondrial cell death factors such as cytochrome c, AIF
and endonuclease G as well as increasing oxidative stress [5,6]. Thus, it
is easily conceivable that mitophagy protects against APAP-induced
liver injury by simply removing these damaged mitochondria in hepa-
tocytes. We previously demonstrated that APAP induces unique zonated
changes in mouse livers due to different metabolic functions/activities
in these liver zone areas [43]. APAP-induced necrosis mainly occurs in
the central vein areas because of the enrichment of Cyp2e1 in these
areas. APAP-induced mitophagy occurs adjacent to the necrosis areas
likely serves as a protective barrier to restrict the expansion of necrosis
in the liver. In contrast, increased hepatocyte proliferation and mi-
tochondria biogenesis occur in the outer layer of the hepatocytes that
are adjacent to the portal vein area [43,44]. Because of these unique
different zone changes after APAP, one has to be cautious with the data
interpretation for mitochondrial changes when using isolated mi-
tochondria from the whole liver. This probably explains why we did not
see significant impaired mitochondrial OCR in WT, PINK1 KO and
Parkin KO mice after APAP treatment. However, we did observe de-
creased levels of mitochondrial OCR in isolated mitochondria from
APAP-treated PINK1 and Parkin DKO mice. These data may suggest that
impaired mitochondrial functions in APAP-treated PINK1 and DKO
mice, which could be either due to impaired mitophagy or decreased
mitochondrial biogenesis or both. Future work to use microdissection to
isolate mitochondrial directly from different liver zone areas would
help to clarify the zonated changes of mitochondria and their con-
tributions in APAP-induced liver injury.
In conclusion, we found that Parkin and PINK1 may reciprocally
compensate for each other in regulating mitophagy in addition to
working in a linear pathway in regulating mitophagy in APAP-treated
mouse livers. Double deletion of Parkin and PINK1 severely impaired
mitophagy in mouse livers resulting in exacerbated liver injury and
mortality after APAP overdose. The molecular and cellular events of
PINK1-Parkin-mediated mitophagy in APAP-induced liver injury is
summarized in Fig. 10.
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Fig. 10. A proposed model for PINK1-Parkin-mediated mitophagy in APAP-induced liver injury. In hepatocytes, APAP is first metabolized through the Cyp2E1 and
generates reactive metabolites NAPQI, which bind to cellular and mitochondrial proteins to form APAP-adducts (APAP-AD) that damage mitochondria. Damaged
mitochondria can lead to necrotic cell death and subsequent liver injury. PINK1 is stabilized on damaged mitochondria and further recruit Parkin to mitochondrial to
induce ubiquitination of mitochondria, which plays a major role in APAP-induced mitochondrial ubiquitination and mitophagy. In the absence of Parkin, PINK1 can
trigger Parkin-independent mitophagy likely via activating unknown E3 ligase on mitochondria to induce ubiquitination of mitochondria. In the absence of PINK1,
some other unknown E3 ligase could also be recruited to mitochondria to induce ubiquitination of mitochondria independent of PINK1. Both the PINK1-independent
and Parkin-independent mitophagy plays a minor role in APAP-induced mitophagy. The autophagy receptor protein such as p62 is recruited to damaged ubiqui-
tinated mitochondria that further recruits LC3 positive autophagosomes for selective mitophagy, which protects against APAP-induced necrosis by removing da-
maged mitochondria. PINK1 KO and Parkin KO mice have improved survival rate after APAP treatment likely via the mitophagy-independent functions. Double
deletion of PINK1 and Parkin in mice decreases mitophagy, exacerbates APAP-induced liver injury and mortality.
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